- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02875496
Reference Database & Longitudinal Registry of the Normal and Pathological Aging Brain ((BNA™))
Reference Database & Longitudinal Registry of the Normal and Pathological Aging Brain: Brain Network Activation Analysis (BNA™) for the Adult and Elderly Population Using Evoked Response Potentials
Panoramica dello studio
Stato
Descrizione dettagliata
Currently, there is no reliable, bedside, and non-invasive method for assessing connectivity changes in electrophysiological activity of the brain associated with brain-related pathologies, e.g., concussion, ADHD, autistic spectrum disorders (ASD), etc. Event Related Potentials (ERPs), which are temporal reflections of the neural mass electrical activity of cells in specific regions of the brain that occur in response to stimuli, may offer such a method, as they provide both a non-invasive and portable measure of brain function. The ERPs provide excellent temporal information, but spatial resolution for ERPs has traditionally been limited. However, by using high-density electroencephalograph (EEG) recording, spatial resolution for ERPs is improved significantly. The paradigm for the current study will combine neurophysiological knowledge with mathematical signal processing and pattern recognition methods (BNA) to temporally and spatially map brain function, connectivity and synchronization.
The need of objective measures that will help the clinician in its decision-making in brain-related pathologies is recognized. BNA is a new imaging modality that has been developed to fill this gap.
Tipo di studio
Iscrizione (Anticipato)
Contatti e Sedi
Luoghi di studio
-
-
Florida
-
The Villages, Florida, Stati Uniti, 32162
- Reclutamento
- The Villages Health
-
Contatto:
- Carla VanderWeerd, PhD
- Numero di telefono: 352-674-8859
- Email: research@thevillageshealth.com
-
Investigatore principale:
- Jeffrey Lowenkron, MD
-
Investigatore principale:
- Carla VanderWeerd, PhD
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
For ALL arms:
Inclusion Criteria:
- Currently resides in The Villages community
- Age 50-years and above.
- Able to speak, read and understand English
- Willingness to participate and able to give informed consent.
- If corrected vision: only Glasses should be used during the study testing
Exclusion Criteria:
- Currently with lice or open wounds on scalp.
- Any CNS neurologic disorder
- Significant sensory deficits.
- Use of a hearing aid that occupies the ear canal
- Any neuropsychological disorders
- History of special education
- Substance abuse in the last 3 months
- History of any clinically significant brain trauma as determined by the investigator.
- Clinically diagnosed with a concussion in the past year.
For Arm 1 Healthy
Inclusion Criteria:
- BDI score <14
- Subjects Not meeting diagnostic criteria for MDD per the DSM IV-TR,
- MMSE score ≥25
Exclusion Criteria:
- Any chronic disease or condition which affects the nervous system as determined by clinical neurological evaluation, medical history or PI discretion.
- Any psychiatric disorder,
- History of any medication affecting CNS within the last 3 months
For Arm 2 Early Alzheimer's Disease
Inclusion Criteria:
- BDI score <14
- Subjects Not meeting diagnostic criteria for MDD per the DSM IV-TR, as determined by clinical evaluation by a research clinician and the Mini International Neuropsychiatric Interview (MINI).
- MMSE score <24
- MoCA<20
- Presence of an early and significant episodic memory impairment
Exclusion Criteria:
- Any chronic disease or condition other than current pathology
- Any other psychiatric disorder
- CNS medications within the short period of time prior to the EEG testing which are not in a medically stable treatment phase.
For Arm 3 Depression
Inclusion Criteria:
- BDI score >14
- Subjects meeting full diagnostic criteria for MDD without psychotic features per the DSM IV-TR
- HAM-D 17-item: Total score of 16 or higher at visit 1.
Exclusion Criteria:
- Any chronic disease or condition other than current pathology
- Any psychiatric disorder other than Depression
- CNS medications within the short period of time prior to the EEG testing which are not in a medically stable treatment phase.
For Arm 4 Mild Cognitive Impairment
Inclusion Criteria:
- BDI score <14
- Subjects Not meeting diagnostic criteria for MDD per the DSM IV-TR
- MMSE scores according to Number of years of Education:
MMSE score Years of Education 17-18 ≤6 20-21 7-8 23-24 ≥10
-20<MoCA score >26
Exclusion Criteria:
- Any chronic disease or condition other than current pathology
- Any other psychiatric disorder
- CNS medications within the short period of time prior to the EEG testing which are not in a medically stable treatment phase.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
|---|
|
Healthy aging
Subjects meeting criteria for healthy aging No intervention administered
|
|
Early Alzheimer Disease
Subjects meeting criteria for Early Alzheimer Disease No intervention administered
|
|
Depression
Subjects meeting criteria for Depression No intervention administered
|
|
MCI-Mild Cognitive Impairment
Subjects meeting criteria for MCI-Mild Cognitive Impairment No intervention administered
|
|
General Arm
Subjects not meeting criteria for any of the other arms (Healthy, Early Alzheimer's, Depression, or MCI)
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Developing a BNA database for healthy aging population.
Lasso di tempo: 2 years
|
Functional networks of brain activity in healthy aging individuals measured using analysis of EEG Event Related Potential (ERP) data Clinical assessments battery will be utilized in order to establish different sets of BNA database for age related pathology and healthy aging.
|
2 years
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Jeffrey Lowenkron, MD, Chief Medical Officer, The Villages Health
- Investigatore principale: Carla VandeWeerd, PhD, Director of Research, The Villages Health
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Anticipato)
Completamento dello studio (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- ELM-26
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .